Comparative Analysis of the Efficacy of Abrocitinib and Dupilumab in the Treatment of Atopic Dermatitis

Both Abrocitinib and Dupilumab are effective and well-tolerated treatments for atopic dermatitis. While their overall efficacy and safety profiles are comparable, Abrocitinib offers superior relief of pruritus. Both therapies represent valuable options in the management of moderate to severe atopic dermatitis.